Invivoscribe is a precision diagnostics company specializing in molecular and flow diagnostics for hematologic oncology. With 30+ years of experience, it develops and manufactures B- and T-cell clonality assays, companion diagnostics (CDx), NGS gene panels, NGS and flow MRD assays, and bioinformatics software under ISO 13485. Through its LabPMM clinical laboratories, Invivoscribe provides internationally standardized testing to hospitals, cancer centers, and pharma in over 160 countries.